Published on 17 May 2024 on Simply Wall St. via Yahoo Finance
Phibro Animal Health Corporation (NASDAQ:PAHC) shareholders will have a reason to smile today, with the analysts making substantial upgrades to next year's forecasts. The consensus estimated revenue numbers rose, with their view now clearly much more bullish on the company's business prospects. Phibro Animal Health has also found favour with investors, with the stock up a notable 10% to US$18.11 over the past week. Could this upgrade be enough to drive the stock even higher?
Following the upgrade, the current consensus from Phibro Animal Health's three analysts is for revenues of US$1.2b in 2025 which - if met - would reflect a meaningful 17% increase on its sales over the past 12 months. Statutory earnings per share are presumed to soar 120% to US$0.71. Before this latest update, the analysts had been forecasting revenues of US$1.0b and earnings per share (EPS) of US$0.71 in 2025. There's clearly been a surge in bullishness around the company's sales pipeline, even if there's no real change in earnings per share forecasts.